Tonix Pharmaceuticals Holding Corp. filed 2 current reports with the SEC under Item 5.02, which covers directors and officers leaving or being appointed, the latest on 2026-08-18. Between them they name 1 person. Each change below is quoted from the filing and linked to it.
Every change, newest first
Appointed: Seth Lederman, Chief Medical Officer
Interim Chief Medical Officer On August 18, 2026, the Board of Directors of Tonix Pharmaceuticals Holding Corp. (the "Company") appointed Dr. Seth Lederman, the Company's President and Chief Executive Officer, as the Company's Interim Chief Medical Officer.
Reported
On July 20, 2026, Dr. Gregory M. Sullivan informed Tonix Pharmaceuticals Holding Corp. (the "Company") that he will retire from his role as Chief Medical Officer of the Company, effective August 20, 2026.
Find people with the same kind of experience as the Chief Medical Officer at Tonix Pharmaceuticals Holding Corp., with the record behind each one.
Find candidates like Chief Medical Officer at Tonix Pharmaceuticals Holding Corp.New leaders review vendors and budgets in their first months. Get an alert the next time Tonix Pharmaceuticals Holding Corp. is in the news or changes leadership.
Get an alert when Tonix Pharmaceuticals Holding Corp. changes leadershipTools for this story
Each opens in a new tab, filled in for Tonix Pharmaceuticals Holding Corp.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.